This presentation was part of a symposium that took place on 17th June 2023, as part of the European Renal Association (ERA) 60th Congress.
Chairperson: Smeeta Sinha1
Speakers: Jan Kielstein,2 Maria Jesus Lloret3
1. Department of Renal Medicine, Salford Royal NHS Foundation Trust, UK
2. Department of Nephrology, Rheumatology and Blood Purification, Academic Teaching Hospital Braunschweig, Germany
3. Dialysis Unit, Fundació Puigvert, Barcelona, Spain
Disclosure: The speakers received fees from Vifor Pharma.
Disclaimer: The opinions expressed in this article belong solely to the named authors.
Support: The publication of this feature was supported and reviewed by Vifor Pharma.
Watch Jan Kielstein’s talk ‘Importance of early and effective treatment of SHPT in non-dialysis CKD patients’ from ERA 2023 below.
Do you know why it’s so important to diagnose and treat secondary hyperparathyroidism early? In Kielstein’s presentation, he goes through a patient case study to illustrate this point as well as other recommendations for optimal management. He discusses the treatment landscape for non-dialysis CKD and demonstrates how different treatment options can alter the different aspects of this condition.
Find out more below.
Key
CKD: chronic kidney disease
HQ-NA-2300114 | August 2023
